← Back to all trials
Completed
NCT05171673
Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury
Conditions: Soft Tissue Injuries
Sex: All
Ages: 6 Years – 45 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 151
Sponsor: IBSA Institut Biochimique SA
Location: Applied Research Center Little Rock Arkansas
Summary
A multi-center, prospective, open-label, controlled study of the pharmacokinetics and safety of the LicartTM topical system in pediatric and adult participants with minor soft tissue injuries. 150 male and female participants aged 6-16 and 18-45 with soft tissue injuries meeting the following criteria will be enrolled to evaluate the pharmacokinetics and safety of the Licart topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. The analgesic effects will also be evaluated of the topical system in pediatric and adult participants with minor soft tissue injuries over a 14-day treatment course. To collect principal investigator-reported global response to therapy.
Eligibility Criteria
Inclusion Criteria:
1. Willing to provide written informed consent;
2. Male or female, 6-11 years old; 12-16 years old; or 18-45 years old;
3. BMI \
Source: ClinicalTrials.gov (NCT05171673). StuddyBuddy aggregates publicly available trial information.